Ted W. Love

CIK: 0001188919

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)8 (80.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (5)

LSTA

LISATA THERAPEUTICS, INC.

Director

JAZZ

Jazz Pharmaceuticals plc

Director

GPCR

Structure Therapeutics Inc.

Director

RPRX

Royalty Pharma plc

Director

GILD

GILEAD SCIENCES, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (10 total)

JAZZ
Jazz Pharmaceuticals plc
Aug 31, 2026
Tax Payment(F)
Direct
737 shares at avg. $241.39$178K
JAZZ
Jazz Pharmaceuticals plc
Aug 31, 2026
Tax Payment(F)
Direct
6 shares at avg. $244.06$1K
JAZZ
Jazz Pharmaceuticals plc
Aug 5, 2026
Award(A)
Direct
1.6K shares-
GPCR
Structure Therapeutics Inc.
Jun 17, 2026
Award(A)
Share Option (right to buy)
Direct
39.5K shares-
RPRX
Royalty Pharma plc
Jun 5, 2026
Award(A)
Direct
4.5K shares-
GILD
GILEAD SCIENCES, INC.
Apr 30, 2026
Award(A)
Direct
1.1K shares-
JAZZ
Jazz Pharmaceuticals plc
Feb 26, 2026
Award(A)
Direct
1.5K shares-
GPCR
Structure Therapeutics Inc.
Jun 23, 2025
Award(A)
Share Option (right to buy)
Direct
51.8K shares-
RPRX
Royalty Pharma plc
May 13, 2025
Award(A)
Direct
7.6K shares-
GILD
GILEAD SCIENCES, INC.
May 7, 2025
Award(A)
Direct
1.5K shares-

		Type	Shares	Price		Ownership
Aug 31, 2026	JAZZ Jazz Pharmaceuticals plc	Tax Payment(F)	737	$241.39	$177,904	Direct
Aug 31, 2026	JAZZ Jazz Pharmaceuticals plc	Tax Payment(F)	6	$244.06	$1,464	Direct
Aug 5, 2026	JAZZ Jazz Pharmaceuticals plc	Award(A)	1,605	-	$0	Direct
Jun 17, 2026	GPCR Structure Therapeutics Inc.	Award(A) Share Option (right to buy)	39,453	-	-	Direct
Jun 5, 2026	RPRX Royalty Pharma plc	Award(A)	4,545	-	$0	Direct
Apr 30, 2026	GILD GILEAD SCIENCES, INC.	Award(A)	1,146	-	$0	Direct
Feb 26, 2026	JAZZ Jazz Pharmaceuticals plc	Award(A)	1,527	-	$0	Direct
Jun 23, 2025	GPCR Structure Therapeutics Inc.	Award(A) Share Option (right to buy)	51,804	-	-	Direct
May 13, 2025	RPRX Royalty Pharma plc	Award(A)	7,614	-	-	Direct
May 7, 2025	GILD GILEAD SCIENCES, INC.	Award(A)	1,516	-	-	Direct

1-10 of 10 transactions

About LOVE TED W

LOVE TED W (SEC CIK 0001188919) files insider reports with the SEC as Director of LISATA THERAPEUTICS, INC. (LSTA), Director of Jazz Pharmaceuticals plc (JAZZ) and Director of Structure Therapeutics Inc. (GPCR). Signal8 also holds filings tied to 2 other companies.

Signal8 holds 11 ownership filings by LOVE TED W (2 Form 3, 9 Form 4), filed between May 8, 2025 and Sep 28, 2026. Those filings report 10 transactions, from May 7, 2025 to Aug 31, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on LOVE TED W's filings is in LIBERTY CORNER, NJ.

Recent filings by LOVE TED W

Aug 31, 2026: Tax withholdings of JAZZ shares (2 lines, Form 4, code F).
Aug 5, 2026: Grant or award of JAZZ shares (Form 4, code A).
Jun 17, 2026: Grant or award of GPCR derivative securities (Form 4, code A).
Jun 5, 2026: Grant or award of RPRX shares (Form 4, code A).
Apr 30, 2026: Grant or award of GILD shares (Form 4, code A).

Other insiders filing for LISATA THERAPEUTICS, INC. (LSTA)

Farrow Jeffrey S, Director
Lehrer-Graiwer Joshua, President & COO
Mazzo David J, President & CEO
Nisco James, SVP, Fin/Treas, Chief Actg Off
Imam Tariq, SVP, Bus Dev, General Counsel
Buck Kristen K, EVP, R&D and CMO

How to read Form 4 transaction codes